BNP Paribas Financial Markets
NWBO

BNP Paribas Financial Markets’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

BNP Paribas Financial Markets’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,432
Closed -$30.2K – 3601
2015
Q4 		$30.2K Sell
9,432
-279
-3% -$1.34K ﹤0.01% 3118
2015
Q3 		$60.7K Buy
9,711
+5,816
+149% +$54.4K ﹤0.01% 2720
2015
Q2 		$38.7K Buy
3,895
+2,481
+175% +$21.7K ﹤0.01% 2643
2015
Q1 		$10.4K Buy
+1,414
New +$9.52K ﹤0.01% 2728
2014
Q4 		– Sell
-2,743
Closed -$13.8K – 4196
2014
Q3 		$13.8K Buy
+2,743
New +$16.9K ﹤0.01% 3408

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's NWBO Position: Q1 2016 in Review

BNP Paribas Financial Markets sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2016, closing a stake of 9,432 shares — an estimated $30.2K sold.

BNP Paribas Financial Markets first reported a position in NWBO in Q3 2014 and held it in 5 quarters. The position peaked at $60.7K in Q3 2015. 74 funds tracked by Wall St. Rank hold NWBO as of Q1 2016.

  • BNP Paribas Financial Markets reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 9,432 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2016, an estimated $30.2K.
  • BNP Paribas Financial Markets first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2014 and held it in 5 quarters.
  • BNP Paribas Financial Markets's Northwest Biotherapeutics, Inc. Common stock position peaked at $60.7K in Q3 2015.
  • 74 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2016, filed 22 Apr 2016.